Terms: = Kidney tumors AND CALCB, Calcitonin AND Prognosis
7 results:
1. Cancer-related hypercalcemia and potential treatments.
Almuradova E; Cicin I
Front Endocrinol (Lausanne); 2023; 14():1039490. PubMed ID: 37033238
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
[TBL] [Abstract] [Full Text] [Related]
3. Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex.
Hirokawa M; Miyauchi A; Kihara M; Kudo T; Hashimoto Y; Suzuki S; Daa T; Vuong HG; Mitsutake N
Endocr J; 2017 Sep; 64(9):843-850. PubMed ID: 28680002
[TBL] [Abstract] [Full Text] [Related]
4. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
Reagan P; Pani A; Rosner MH
Am J Kidney Dis; 2014 Jan; 63(1):141-7. PubMed ID: 24021907
[TBL] [Abstract] [Full Text] [Related]
5. The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.
Nikitenko LL; Leek R; Henderson S; Pillay N; Turley H; Generali D; Gunningham S; Morrin HR; Pellagatti A; Rees MC; Harris AL; Fox SB
Clin Cancer Res; 2013 Oct; 19(20):5740-8. PubMed ID: 23969937
[TBL] [Abstract] [Full Text] [Related]
6. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment.
Mosekilde L; Eriksen EF; Charles P
Crit Rev Oncol Hematol; 1991; 11(1):1-27. PubMed ID: 1883526
[TBL] [Abstract] [Full Text] [Related]
7. [Paraneoplastic syndrome in kidney cancer].
Strohmaier WL; Bichler KH
Med Klin (Munich); 1989 Feb; 84(2):86-9. PubMed ID: 2710055
[TBL] [Abstract] [Full Text] [Related]
